CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Luoxin Pharmaceuticals Group Stock CoLtd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Luoxin Pharmaceuticals Group Stock CoLtd
Block 4
No. 18 Luoqi Road, Luozhuang District
Phone: +86 2138867666p:+86 2138867666 LINYI, SDG  276017  China Ticker: 002793002793
Business Summary
Luoxin Pharmaceuticals Group Stock Co Ltd is a China-based company primarily engaged in the research and development, production, and sales of pharmaceutical products. The Company focuses on therapeutic areas such as digestive, respiratory, and anti tumor treatments. The Company's products mainly include chemical formulations, active pharmaceutical ingredients (APIs), and traditional Chinese medicines. The Company conducts its operations through two segments. The Pharmaceutical Manufacturing segment engages in the research, development, and production of chemical drug formulations and APIs, with major products including digestive medicines, respiratory medicines, and antibiotics. The Company also operates through the Pharmaceutical Distribution segment. The Company mainly operates its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
3561 Pumps and pumping equipment
7389 Business services, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager ZhentengLiu 40 1/31/2023 4/23/2020
Finance Director YongshengWu 42 9/8/2025 9/8/2025
Secretary of the Board YingJiang 38 10/13/2025 10/13/2025
5 additional Officers and Directors records available in full report.

Business Names
Business Name
002793
2793

General Information
Number of Employees: 3,196 (As of 12/31/2024)
Outstanding Shares: 1,087,588,486 (As of 9/30/2025)
Shareholders: 28,962
Stock Exchange: SHE
Fax Number: +86 2138867600


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026